Webinar

The Implications of the Inflation Reduction Act on Medicare Drug Strategies

Dec. 7, 2022 , 2:00 pm – 3:00 pm
Contact Leenah Hegazy (202) 942-4263
  • Event

    The Implications of the Inflation Reduction Act on Medicare Drug Strategies

    Following the recent passage of the Inflation Reduction Act (IRA), counties now have an opportunity to rethink how they provide prescription drug benefits for Medicare-eligible retirees. The new law includes significant design and financing changes to Medicare Part D so, regardless of how your county currently provides prescription drug coverage today, now is a good time to revisit your options.

    This webinar with NACo Corporate Partner, Buck, will offer insight into the following topics:

    • The practical and strategic implications of the IRA’s changes to Medicare Part D
    • The impact of the financing changes on plan design and funding, including:
      • Will the IRA impact Creditable Coverage determination for active plans?
      • Will sponsors still qualify for Retiree Drug Subsidy after IRA?
      • How will Employer Group Waiver Plans (EGWP) be impacted by the IRA’s changes to design and funding?
    • Will the IRA impact GASB 74/75 costs and liabilities?
    • Steps you should take now to address the IRA and questions for your actuary
    Following the recent passage of the Inflation Reduction Act (IRA), counties now have an opportunity to rethink how they provide prescription drug benefits for Medicare-eligible retirees.
    2022-12-07
    Webinar
    2022-11-28

Following the recent passage of the Inflation Reduction Act (IRA), counties now have an opportunity to rethink how they provide prescription drug benefits for Medicare-eligible retirees. The new law includes significant design and financing changes to Medicare Part D so, regardless of how your county currently provides prescription drug coverage today, now is a good time to revisit your options.

This webinar with NACo Corporate Partner, Buck, will offer insight into the following topics:

  • The practical and strategic implications of the IRA’s changes to Medicare Part D
  • The impact of the financing changes on plan design and funding, including:
    • Will the IRA impact Creditable Coverage determination for active plans?
    • Will sponsors still qualify for Retiree Drug Subsidy after IRA?
    • How will Employer Group Waiver Plans (EGWP) be impacted by the IRA’s changes to design and funding?
  • Will the IRA impact GASB 74/75 costs and liabilities?
  • Steps you should take now to address the IRA and questions for your actuary